Blog

Nermean Mostafa: Great pleasure to participate in RTD Side Event during ESMO 2024

Photo taken from Nermean Mostafa/LinkedIn

Oct 2, 2024, 23:57

Nermean Mostafa: Great pleasure to participate in RTD Side Event during ESMO 2024

Nermean Mostafa, Head of Clinical Oncology unit at Ain shams University, posted the following on LinkedIn:

“It was a great pleasure to actively participate in RTD Side Event during ESMO 2024 about the HCC patient journey. The meeting was a great opportunity to share insights and feedback from stakeholders, patient advocates groups, different members from international Liver communities networking with different representatives from international organizations and societies for better patient outcomes.”

Source: Nermean Mostafa/LinkedIn

cancer ESMO 2024 HCC patient journey international liver communities international organizations Nermean Mostafa networking OncoDaily Oncology patient advocate groups patient outcomes RTD Side Event stakeholder insights

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage